Credit Suisse Downgrades Spectrum Pharmaceuticals (SPPI) to Underperform
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Price: $1.03 --0%
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 8 | New: 18
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 8 | New: 18
Join SI Premium – FREE
Credit Suisse downgraded Spectrum Pharmaceuticals (NASDAQ: SPPI) from Neutral to Underperform.
For an analyst ratings summary and ratings history on Spectrum Pharmaceuticals click here. For more ratings news on Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $8.01 yesterday.
For an analyst ratings summary and ratings history on Spectrum Pharmaceuticals click here. For more ratings news on Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $8.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades Netskope (NTSK) to Hold on Valuation
- RBC Capital Downgrades EyePoint Inc. (EYPT) to Sector Perform
- UBS Downgrades Scor SE (SCR:FP) (SCRYY) to Sell
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
